Mostafa Faisal: Donor Type and Long-Term Quality of Life After HCT for Severe Aplastic Anemia
Mostafa Faisal, Associate Professor of Clinical Hematology and HSCT at Assiut University, shared a post on X about a recent article by Matty Slaught et al., published in Transplantation and Cellular Therapy, adding:
“Comparison of Late Effects and Quality of Life by Donor Type in Long-Term Survivors of Severe Aplastic Anemia after Hematopoietic Cell Transplantation.
Long-term SAA HCT survivors:
- 122 survivors; median 26 years after HCT
- 49% employed full-time, 24% part-time
- Common late effects: sexual dysfunction 35%, cataracts 20%, low bone density 20%
- 34% required antihypertensive therapy
Alternative-donor HCT associated with more musculoskeletal problems (OR 9.9)
SF-36 physical 49.5 and mental 49.9, essentially identical to population norms
No major QOL differences by donor type
Lifelong surveillance remains essential, but long-term QOL is reassuring.”
Title: Comparison of Late Effects and Quality of Life by Donor Type in Long-Term Survivors of Severe Aplastic Anemia after Hematopoietic Cell Transplantation
Authors: Matty Slaught, Lynn Onstad, Paul A. Carpenter, Sioban B. Keel, Catherine J. Lee, Shivaprasad Manjappa, Lauri Burroughs, Rohtesh S. Mehta, Masumi Ueda Oshima, Phuong Vo, K. Scott Baker, Stephanie J. Lee, Neel S. Bhatt

Other posts featuring Mostafa Faisal on Hemostasis Today.
-
Nov 21, 2026, 20:00Jeyda Star: The FAST Signs of Stroke and the Reality of Life Afterward
-
Nov 21, 2026, 19:59Daniel Lindholm: Women Showed the Largest Improvement in Stroke Risk Over Time in Heart Failure
-
Nov 21, 2026, 19:56Neil Arrowsmith: Raising Awareness of Pulmonary Embolism in Young People
-
Nov 21, 2026, 19:52Muhammad Zeeshan Jamal: Thrilled to Present Our Research on Intermediate-Risk Acute PE in Abu Dhabi
-
Nov 21, 2026, 19:50Mounisha Devireddy: Proud to Share Our Research on High-Risk PE in Pregnancy
-
Nov 21, 2026, 19:47Melissa Hollo: How Severe Anemia Increases the Odds of Acute HF During Pregnancy and Postpartum
-
Nov 21, 2026, 19:44Ashenafi Tazebew Amare: Building Sustainable Systems to Close the Anti-D Immunoglobulin Access Gap in LMICs
-
Nov 21, 2026, 19:43Sheharyar Raza: Interpreting Clotting Times Through Reptilase Time and Thrombin Time Assays
-
Nov 21, 2026, 19:42Minoo Ahmadinejad: Serving on the ISTH 2027 Scientific Theme Committee for Women’s Health